Sequence information
Variant position: 492 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1608 The length of the canonical sequence.
Location on the sequence:
TDSESGDSSGEDPEGNKGFG
R KVFSPVIRSSFTHCRPPLDP
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TDSESGDSS----GEDPEGNKGFGR KVFSPVIRSSFTHCRPPLDP
Mouse TDSESGDSS----GEDPEGNKGFGR KVFSPVIRSSFTHCRP
Drosophila NDSDMDDTPFDYRKQQPEANQRSAE EHSTSGANGQAINAPP
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 1608
Protein capicua homolog
Region
470 – 630
Disordered
Modified residue
496 – 496
Phosphoserine
Literature citations
A de novo paradigm for mental retardation.
Vissers L.E.; de Ligt J.; Gilissen C.; Janssen I.; Steehouwer M.; de Vries P.; van Lier B.; Arts P.; Wieskamp N.; del Rosario M.; van Bon B.W.; Hoischen A.; de Vries B.B.; Brunner H.G.; Veltman J.A.;
Nat. Genet. 42:1109-1112(2010)
Cited for: VARIANT MRD45 TRP-492;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.